Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CanX

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of pharmaceutical products. The company engages in drug development and develops synthetically formulated cannabinoids for use in drug-development.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Las Vegas, NV
  • United States

CanX Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore CanX‘s full profile, request access.

Request full access to PitchBook